People are hearing strong trial results, seeing scattered prices online, and trying to compare an investigational treatment with approved medications that already have set pharmacy pathways
it's a GLP-1 receptor agonist that targets the underlying issues commonly associated with type 2 diabetes, including insulin resistance
The processes by which the compounded drugs are manufactured have not been reviewed by the FDA, and FDA-approved products containing semaglutide and tirzepatide are available
Why Tirzepatide Injection Produces Faster First-Month Results Than Some Alternatives Tirzepatide injections deliver medication directly into your bloodstream, allowing faster and more consistent activation of both the GLP-1 and GIP receptors compared to oral formulations
Already, semaglutide trials have returned fewer major adverse cardiovascular events in groups at particularly high risk, and long-term use in people with prediabetes delays or prevents further progression into type 2 diabetes
Phase 2 trials have also highlighted other possible side effects, like injection site reactions
